appengine.ai

Artificial Intelligence | Machine Learning | Machine Perception Cyclica | Decentralize Drug Discovery


Consumer, Biotechnology, Drug Development, Drug Discovery, Medical Toronto, ON, Canada

Cyclica

Artificial Intelligence | Machine Learning | Machine Perception


Cyclica | Decentralize Drug Discovery

Cyclica

Biotechnology, Drug Development, Drug Discovery, Medical


Toronto, ON, Canada

Cyclica is a biotechnology company that leverages AI and computational biophysics to decentralize drug discovery.

The company approaches polypharmacology with a structure-based, AI-augmented in silico discovery platform, centred on Ligand Design and Ligand Express. Powered by MatchMaker™, a proprietary deep learning proteome screening technology, and POEM™, an innovative supervised learning technology for predicting molecular properties, Cyclica’s platform is suited to the design of novel, drug-like chemical matter by simultaneously prioritizing compounds based on their on- and off-target polypharmacological profiles as well as their developmental properties. With a team that has deep roots in the industry, a platform, and an innovative decentralized partnership model, Cyclica is creating medicines with precision for unmet patient needs.

Jason Mitakidis and Naheed Kurji founded the biotech company in Toronto, Ontario in 2013.

 

 

B2C

26 to 50

Series B

$23,807,896

Scaling Up

2013

 
 

Pharmaceuticals
Managed Health Care
Biotechnology

N/A

Driving Drug Discovery

 
 

IT and Security
Service

Yes

Active

 
 

   Machine Learning
   Machine Perception
   Natural Language Processing


Match Maker

Match Maker

POEM

POEM


N/A

 

   Software


NA

NA


NA

NA

 
 

View All

IT Generalist

Toronto, Ontario

Partner Success

Toronto, Ontario

Cloud Security Operations (SecOps)

Toronto, Ontario

Strategic Partnerships Manager

Toronto, Ontario

Associate Computational Scientist (Structural Bioinformatics); Ph.D. or M.Sc.

Toronto, Ontario

 
 
Naheed Kurji


Naheed Kurji
Co-Founder, President & CEO

Andreas Windemuth


Andreas Windemuth
Chief Scientific Officer